AVTX vs XPO · P/E 0.0, $51.5M cap vs P/E 69, rev $2.35B
Avalo Therapeutics Inc (AVTX) versus XPO Logistics Inc (XPO) — a side-by-side from cached financials, not a winner call.
Avalo Therapeutics Inc (AVTX) is a biotechnology company listed on US.
XPO Logistics Inc (XPO) is a trucking company listed on NYSE.
Latest reported AVTX revenue for 2025-09-30 was $0. Net income was -$30.6M. AVTX currently screens at market cap $51.5M and trailing P/E 0.0.
Latest reported XPO revenue for 2026-06-30 was $2.35B. Net income was $162.0M. Revenue was up 12.4% from 2026-03-31 to 2026-06-30. XPO currently screens at market cap $23.69B and trailing P/E 69.3.
AVTX currently screens at market cap $51.5M and trailing P/E 0.0. XPO currently screens at market cap $23.69B and trailing P/E 69.3.
Not investment advice. Open the AVTX and XPO stock pages for the full models.
Not investment advice.